Crispr Therapeutics Ag
CRSP
Revenue
35.69M
▲35.09M▲5828.74%
3 Months ChangeAssets
2.24B
▼-14.10M▼-0.6248%
3 Months ChangeLiabilities
309.95M
▼-6.52M▼-2.06%
3 Months ChangeFree Cash Flow
109.03M
▲103.29M▲1799.49%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-05
Form 10-Q
ID: 0000950170-24-090746
2024-08-05
Form 8-K
ID: 0000950170-24-090727
2024-06-03
Form 8-K
ID: 0000950170-24-067660
2024-05-23
Form 8-K
ID: 0000950123-24-005877
2024-05-08
Form 10-Q
ID: 0000950170-24-055719
2024-05-08
Form 8-K
ID: 0000950170-24-055689
2024-02-21
Form 8-K
ID: 0000950170-24-017568
2024-02-13
Form 8-K
ID: 0001193125-24-033973
2024-02-13
Form 8-K
ID: 0001193125-24-032825
2024-01-16
Form 8-K
ID: 0000950170-24-004616